Clinical Trials in Mudanjiang, China
Locations / Mudanjiang, China
Delta Trials lists 29 clinical trials conducted in Mudanjiang, China, making it a notable site of clinical research activity. These trials addressing 44 medical conditions, reflecting the scope and diversity of clinical research in this location. Since 2020, 1 trial in this location have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the Mudanjiang research landscape.
29
Total Trials
44
Conditions
1
Terminated since 2020
Browse by condition (44 total)
- Ischemic stroke 4 trialsAll Ischemic stroke trials
- Polycystic ovary syndrome 2 trialsAll Polycystic ovary syndrome trials
- Cardiovascular diseases 2 trialsAll Cardiovascular diseases trials
- Transient ischemic attack 2 trialsAll Transient ischemic attack trials
- Coronary artery disease 2 trialsAll Coronary artery disease trials
- Syndrome heart disease 1 trialAll Syndrome heart disease trials
- All Percutaneous coronary intervention trials
- Cardioprotection 1 trialAll Cardioprotection trials
- Embolic stroke 1 trialAll Embolic stroke trials
- Drug-induced liver injury 1 trialAll Drug-induced liver injury trials
- Nausea and vomiting of pregnancy 1 trialAll Nausea and vomiting of pregnancy trials
- COVID-19 1 trialAll COVID-19 trials
- Healthy volunteers 1 trialAll Healthy volunteers trials
- Vascular diseases 1 trialAll Vascular diseases trials
- Acute coronary syndrome 1 trialAll Acute coronary syndrome trials
- Ischemic stroke, acute 1 trialAll Ischemic stroke, acute trials
- Heart diseases 1 trialAll Heart diseases trials
- Adverse drug event 1 trialAll Adverse drug event trials
- All Her2-positive advanced breast cancer trials
- Gestational diabetes 1 trialAll Gestational diabetes trials